Healthcare provider profile · identity verified

Andrew M. Dym, M.D.

Internal Medicine · SEATTLE, WA · NPI 1679562409

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	346	83
Levothyroxine Sodium	Levothyroxine Sodium	278	48
Amlodipine Besylate	Amlodipine Besylate	260	73
Gabapentin	Gabapentin	220	50
Lisinopril	Lisinopril	190	49
Tamsulosin Hcl	Tamsulosin Hcl	135	35
Metoprolol Succinate	Metoprolol Succinate	130	33
Lorazepam	Lorazepam	128	28
Omeprazole	Omeprazole	128	27
Oxycodone Hcl	Oxycodone Hcl	128	18
Simvastatin	Simvastatin	122	30
Sertraline Hcl	Sertraline Hcl	109	24
Losartan Potassium	Losartan Potassium	108	29
Hydrochlorothiazide	Hydrochlorothiazide	103	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	22
Metformin Hcl	Metformin Hcl	103	29
Metformin Hcl Er	Metformin Hcl	96	28
Trazodone Hcl	Trazodone Hcl	85	23
Citalopram Hbr	Citalopram Hydrobromide	79	16
Furosemide	Furosemide	77	14
Famotidine	Famotidine	74	11
Allopurinol	Allopurinol	72	13
Zolpidem Tartrate	Zolpidem Tartrate	71	16
Glipizide	Glipizide	69	18
Diazepam	Diazepam	66	suppressed
Potassium Chloride	Potassium Chloride	63	12
Divalproex Sodium Er	Divalproex Sodium	62	suppressed
Eliquis	Apixaban	62	12
Tramadol Hcl	Tramadol Hcl	59	suppressed
Finasteride	Finasteride	58	18
Alprazolam	Alprazolam	55	suppressed
Paroxetine Hcl	Paroxetine Hcl	53	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	52	suppressed
Atenolol	Atenolol	50	13
Pantoprazole Sodium	Pantoprazole Sodium	48	11
Albuterol Sulfate Hfa	Albuterol Sulfate	47	21
Lovastatin	Lovastatin	46	12
Prednisone	Prednisone	46	29
Chlorhexidine Gluconate	Chlorhexidine Gluconate	45	suppressed
Lamotrigine	Lamotrigine	45	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	12
Rosuvastatin Calcium	Rosuvastatin Calcium	41	12
Mirtazapine	Mirtazapine	40	11
Alendronate Sodium	Alendronate Sodium	38	suppressed
Meloxicam	Meloxicam	36	13
Triamcinolone Acetonide	Triamcinolone Acetonide	34	27
Clonazepam	Clonazepam	32	suppressed
Ketoconazole	Ketoconazole	32	14
Levetiracetam	Levetiracetam	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Methocarbamol	Methocarbamol	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Ozempic	Semaglutide	28	suppressed
Terbinafine Hcl	Terbinafine Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Methadone Hcl	Methadone Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Ibuprofen	Ibuprofen	24	11
Ondansetron Odt	Ondansetron	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Azithromycin	Azithromycin	20	18
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Colchicine	Colchicine	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Phenytoin	Phenytoin	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Estradiol	Estradiol	15	suppressed
Valsartan	Valsartan	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Mupirocin	Mupirocin	14	11
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Baclofen	Baclofen	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Carbatrol	Carbamazepine	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Letrozole	Letrozole	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Naproxen Sodium	Naproxen Sodium	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Gemtesa	Vibegron	11	suppressed
Microgestin	Norethindrone Ac/Eth Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error